Corpus luteum cyst

Summary

Corpus luteum cyst (MONDO:0001625) is a disease. A subtype of ovarian cyst — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	corpus luteum cyst
Mondo ID	MONDO:0001625
DOID	DOID:13050
ICD-10-CM	N83.1
ICD-11	753201214
SNOMED CT	386762009
UMLS	C0010093
MedGen	1142
Anatomy (UBERON)	UBERON:0002512
Is cancer (heuristic)	no

Also known as: corpus luteum ovarian cyst (disease) · ovarian cyst (disease) of corpus luteum

Disease family

This is a subtype of ovarian cyst. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › reproductive system disorder › gonadal disorder › ovarian disorder › ovarian cyst › corpus luteum cyst

Related subtypes (2): malignant ovarian cyst, neonatal ovarian cyst

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.